Showing results (171-180 of 177) with videos related to
Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 177 results.
Cancer Immunology, Immunotherapy : CII|August 11, 2012
T cell profiling reveals high CD4+CTLA-4 + T cell frequency as dominant predictor for survival after prostate GVAX/ipilimumab treatmentSaskia J A M Santegoets, Anita G M Stam, Sinéad M Lougheed, et al.Plos One|July 23, 2013
IL-10 conditioning of human skin affects the distribution of migratory dendritic cell subsets and functional T cell differentiationJelle J Lindenberg, Dinja Oosterhoff, Claudia C Sombroek, et al.Cancer Immunology Research|January 31, 2015
Arming the Melanoma Sentinel Lymph Node through Local Administration of CpG-B and GM-CSF: Recruitment and Activation of BDCA3/CD141(+) Dendritic Cells and Enhanced Cross-PresentationBerbel J R Sluijter, Mari F C M van den Hout, Bas D Koster, et al.Oncotarget|October 27, 2015
Multifactorial resistance to aminopeptidase inhibitor prodrug CHR2863 in myeloid leukemia cells: down-regulation of carboxylesterase 1, drug sequestration in lipid droplets and pro-survival activation ERK/Akt/mTORSue Ellen Verbrugge, Marjon Al, Yehuda G Assaraf, et al.Oncoimmunology|October 25, 2019
Constitutively active GSK3β as a means to bolster dendritic cell functionality in the face of tumour-mediated immune suppressionMarta López González, Dinja Oosterhoff, Jelle J Lindenberg, et al.The Lancet. Oncology|February 14, 2012
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trialAlfons J M van den Eertwegh, Jurjen Versluis, H Pieter van den Berg, et al.Journal of Translational Medicine|December 16, 2011
Defining the critical hurdles in cancer immunotherapyBernard A Fox, Dolores J Schendel, Lisa H Butterfield, et al.Pageof 18